Auro Laboratories Intrinsic Value
AUROLAB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹101.20 | ₹80.96 - ₹121.44 | -63.9% | EPS: ₹4.60, Sector P/E: 22x |
| Book Value Method | asset | ₹143.33 | ₹129.00 - ₹157.66 | -48.8% | Book Value/Share: ₹71.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹133.33 | ₹120.00 - ₹146.66 | -52.4% | Revenue/Share: ₹66.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹189.00 | ₹170.10 - ₹207.90 | -32.5% | EBITDA: ₹12.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹111.98 | ₹89.58 - ₹134.38 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹83.98 | ₹75.58 - ₹92.38 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹83.98 | ₹75.58 - ₹92.38 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹139.97 | ₹125.97 - ₹153.97 | -50.0% | ROE: 9.3%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹86.12 | ₹77.51 - ₹94.73 | -69.2% | EPS: ₹4.60, BVPS: ₹71.67 |
Want to compare with current market value? Check AUROLAB share price latest .
Valuation Comparison Chart
AUROLAB Intrinsic Value Analysis
What is the intrinsic value of AUROLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Auro Laboratories (AUROLAB) is ₹111.98 (median value). With the current market price of ₹279.95, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹83.98 to ₹189.00, indicating ₹83.98 - ₹189.00.
Is AUROLAB undervalued or overvalued?
Based on our multi-method analysis, Auro Laboratories (AUROLAB) appears to be trading above calculated value by approximately 60.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.63 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.30 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 9.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.40x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Auro Laboratories
Additional stock information and data for AUROLAB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹6 Cr | ₹-7 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹19 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹-7 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹13 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |